India reviewing Pfizer’s emergency use application, detailed plans in place for vaccination programme: Health Minister Harsh Vardhan
Emphasising “atmanirbharta” or self-reliance, the minister said India’s focus is on developing an indigenous vaccine, adding that our vaccine manufacturing capacities “are not less than anyone.”
Union Health Minister Harsh Vardhan
Union Health Minister Harsh Vardhan has said that the Drug Controller General of India (DGCI) is “examining” Pfizer India’s application for emergency use authorisation (EUA) application of its COVID-19 vaccine.
In an interview with ANI, he said he is aware of the application and that regulators are examining the same. Adding: “If a politician speaks on the matter which is in the jurisdiction of experts, it will not be appropriate.perhaps they did not take part in the meeting.”
Current Affairs in Short: 21 December 2020 jagranjosh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagranjosh.com Daily Mail and Mail on Sunday newspapers.
Markets plunge on news of mutant virus
Updated:
Updated:
Worst single-day fall in seven months
Share Article
Worst single-day fall in seven months
Fears of a rapidly spreading new strain of the COVID-19 virus in the U.K. caused a bloodbath in Indian equity markets, with key benchmark indices slumping 3%. The rupee declined to a two-week low at 73.79 against the U.S. dollar.
Global equities too tumbled, the dollar strengthened and volatility surged across asset classes as news of the new strain threatened to torpedo markets’ optimism over a vaccine-fuelled rebound in economic growth.
U.K. equities were down just over 2%, while European equities fell around 2.5%. Futures for the S&P 500 fell 1.8%, recouping some earlier falls, while Nasdaq futures were down 1.2%. Gold, which usually rises during times of turmoil, fell as much as 1.3% in the global markets before clawing back some of that loss.
Updated Dec 20, 2020 | 23:44 IST
Presently, three COVID-19 vaccine candidates – Bharat Biotech, Serum Institute of India (SII) and Pfizer, are under active consideration of Drugs Controller General of India (DCGI), country’s drug regulator. Representational Image | Photo Credit: PTI
Key Highlights
The health ministry recently said that the vaccination against the coronavirus disease is voluntary
The ministry said vaccines will be introduced in the country only after the regulatory bodies clear it
New Delhi: Union Health Minister Harsh Vardhan, on Sunday, said that the first dose of COVID-19 could be administered to the people of the country in January.
“India is not less than any country when it comes to COVID-19 vaccine and research. Our first priority has been the safety and efficacy of the vaccine. We do not want any comprise on that. Our regulators are analysing them with seriousness, Vardhan was quoted as saying by ANI.
India recognised COVID-19 threat early, pursued scientific evidence-based approach: Health Minister Harsh Vardhan
It has been almost one year since the outbreak of COVID-19. While the caseload infection in many parts of the world is decreasing, many others are experiencing a second or even a third peak. Fortunately, in India, the cases are steadily coming down, said Union Health Minister Harsh Vardhan. PTI
coronavirus, COVID-19 pandemic, coronavirus in india, Harsh Vardhan, COVID-19 in india / December 17, 2020 / 10:01 PM IST
Union Health Minister Harsh Vardhan
COVID-19 cases in India are steadily coming down while the caseload of infection in many parts of the world is experiencing a second or even a third peak, Union Health Minister Harsh Vardhan said on December 17, asserting that the government recognised the threat early and pursued a scientific evidence-based approach .